3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
14
Burkitt Lymphoma
10
Neoplasms
7
Lymphoma, Follicular
6
Hodgkin Disease
6
Triple Negative Breast Neoplasms
5
Sarcoma
5
Ovarian Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Endometrial Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell
4
Breast Neoplasms
4
Wilms Tumor
3
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Lymphoma, Mantle-Cell
3
Liposarcoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Fallopian Tube Neoplasms
3
Plasmablastic Lymphoma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphoma, B-Cell, Marginal Zone
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Interventions
Cisplatin
13
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Radiotherapy
7
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
Radiotherapy, Intensity-Modulated
4
Radiation
4
Biopsy
4
Surveys and Questionnaires
3
Nivolumab
3
Carboplatin
3
pembrolizumab
2
durvalumab
2
Observation
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Docetaxel
2
Disulfides
2
Chemoradiotherapy
2
Cetuximab
2
(225)Ac-DOTA-c(RGDyK)
2
niraparib
1
merphos
1
ipatasertib
1
dostarlimab
1
cemiplimab
1
cabozantinib
1
balstilimab
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
Doxorubicin
×
30 days
×
Clear all
No trials found.